25 results
Onset of Intramuscular (IM) Medications for Severe Agitation
Ketamine (2-5 mg/kg IM) 3-7m
Droperidol (5 mg IM) 5-10m
Midazolam
Intramuscular (IM ... ) Medications for ... Ketamine (2-5 mg/kg ... #Medications #Agitation ... Agitation #Duration #Pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... Papillomavirus Infections ... 6.11.16,18,31,33,45,52,58) 0.5mL IM ... HumanPapillomavirus #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... IV or IM daily ... opportunistic #infections ... #HIVAIDS #pharmacology
Differential Diagnosis of Hypoglycemia
Evaluation of Hypoglycemia
Patients with known diabetes who are not systemically ill and can
- LFT - EtOH - Infectious ... blood cultures - ECG ... antibodies #Diagnosis #EM ... #IM #Hypoglycemia
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicillium marneffei Infections ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... #HIVAIDS #pharmacology
Emergency Treatment Algorithm for Convulsive Status Epilepticus
1. ABCDEFG (ABC's and Don't Ever Forget the Glucose)
2. Airway:
Lorazepam 0.1 mg/kg ... Midazolam 10 mg IM ... Phenytoin 20 mg/kg ... Refractory medications ... Management #Neurology #Pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Nifurtimox 8–10 mg/kg ... Trypanosomiasis #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Tocilizumab 4-8mg/kg ... respiratory tract infection ... Siltuximab 11mg/kg ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... other factors (e.g ... ., concomitant medications ... Cytomegalovirus #CMV #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... Coccidiodomycosis #IDSA ... #HIVAIDS #pharmacology